New Tricks for an Old Natural Product: Discovery of Highly Potent Evodiamine Derivatives as Novel Antitumor Agents by Systemic Structure–Activity Relationship Analysis and Biological Evaluations
The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Evodiamine is a quinazolinocarboline alkaloid isolated from the fruits of traditional Chinese herb Evodiae fructus . Previously, we identified N13-substituted evodiamine derivatives as potent topoisomerase I inhibitors by structure-based virtual screening and lead optimization. Herein, a library of novel evodiamine derivatives bearing various substitutions or modified scaffold were synthesized. Among them, a number of evodiamine derivatives showed substantial increase of the antitumor activity, with GI(50) values lower than 3 nM. Moreover, these highly potent compounds can effectively induce the apoptosis of A549 cells. Interestingly, further computational target prediction calculations in combination with biological assays confirmed that the evodiamine derivatives acted by dual inhibition of topoisomerases I and II. Moreover, several hydroxyl derivatives, such as 10-hydroxyl evodiamine (10j) and 3-amino-10-hydroxyl evodiamine (18g), also showed good in vivo antitumor efficacy and low toxicity at the dose of 1 mg/kg or 2 mg/kg. They represent promising candidates for the development of novel antitumor agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen
Jones, G., Willett, P., Glen, R. C., Leach, A. R., & Taylor, R. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0897 · Cited by 6,763
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Natural products as sources of new drugs over the period 1981–2002
Newman, D. J., Cragg, G. M., & Snader, K. M. (2003) · Journal of Natural Products · doi:10.1021/np030096l · Cited by 3,082
Molecular dynamics---Scalable algorithms for molecular dynamics simulations on commodity clusters
Bowers, K. J., Sacerdoti, F. D., Salmon, J. K., Shan, Y., Shaw, D. E., Chow, E., Xu, H., Dror, R. O., Eastwood, M. P., Gregersen, B. A., et al. (2006) · Proceedings of the 2006 ACM/IEEE conference on Supercomputing - SC '06 · doi:10.1145/1188455.1188544 · Cited by 2,580
Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.
Hsiang, Y. H., Hertzberg, R., Hecht, S., & Liu, L. F. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38654-4 · Cited by 2,362
Wall, M. E., Wani, M. C., Cook, C. E., Palmer, K. H., McPhail, A. T., & Sim, G. A. (1966) · Journal of the American Chemical Society · doi:10.1021/ja00968a057 · Cited by 2,258
Targeting DNA topoisomerase II in cancer chemotherapy
Nitiss, J. L. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2607 · Cited by 1,791
Is There a Difference between Leads and Drugs? A Historical Perspective
Oprea, T. I., Davis, A. M., Teague, S. J., & Leeson, P. D. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010366a · Cited by 769
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
Pommier, Y. (2009) · Chemical Reviews · doi:10.1021/cr900097c · Cited by 707
All tangled up: how cells direct, manage and exploit topoisomerase function
Vos, S. M., Tretter, E. M., Schmidt, B. H., & Berger, J. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3228 · Cited by 650
García‐Carbonero, R., & Supko, J. G. (2002) · PubMed · Cited by 550
Kingsbury, W. D., Boehm, J. C., Jakas, D. R., Holden, K. G., Hecht, S. M., Gallagher, G., Caranfa, M. J., McCabe, F. L., Faucette, L. F., Johnson, R. K., et al. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00105a017 · Cited by 518
Pursuing the leadlikeness concept in pharmaceutical research
Hann, M. M., & Oprea, T. I. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.04.003 · Cited by 515
Criteria for the mode of binding of DNA binding agents
Suh, D., & Chaires, J. B. (1995) · Bioorganic & Medicinal Chemistry · doi:10.1016/0968-0896(95)00053-j · Cited by 467
Camptothecin and Taxol: Historic Achievements in Natural Products Research
Oberlies, N. H., & Kroll, D. J. (2004) · Journal of Natural Products · doi:10.1021/np030498t · Cited by 353
Baviskar, A. T., Madaan, C., Preet, R., Mohapatra, P., Jain, V., Agarwal, A., Guchhait, S. K., Kundu, C. N., Banerjee, U. C., & Bharatam, P. V. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200235u · Cited by 294
Contemporary Challenges in the Design of Topoisomerase II Inhibitors for Cancer Chemotherapy
Bailly, C. (2012) · Chemical Reviews · doi:10.1021/cr200325f · Cited by 288
Shaw, D. E. (2005) · Journal of Computational Chemistry · doi:10.1002/jcc.20267 · Cited by 226
Huang, H., Chen, Q., Ku, X., Meng, L., Lin, L., Wang, X., Zhu, C., Wang, Y., Chen, Z., Li, M., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm9014394 · Cited by 197
Kobayashi*, Y., Nakano, Y., Kizaki, M., Hoshikuma, K., Yokoo, Y., & Kamiya, T. (2001) · Planta Medica · doi:10.1055/s-2001-17353 · Cited by 176
Liu, X., Jiang, H., & Li, H. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200060s · Cited by 170
Decker, M. W. (2005) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2004.12.003 · Cited by 166
Dong, G., Sheng, C., Wang, S., Miao, Z., Yao, J., & Zhang, W. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100387d · Cited by 159
Self-citationDual Topoisomerase I / II Inhibitors in Cancer Therapy
Denny, W. A., & Baguley, B. C. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452555 · Cited by 153
Recent Advances in the Development of Dual Topoisomerase I and II Inhibitors as Anticancer Drugs
Salerno, S., Settimo, F. D., Taliani, S., Simorini, F., Motta, C. L., Fornaciari, G., & Marini, A. M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710793361252 · Cited by 152
Ko, H.-C., Wang, Y.-H., Liou, K., Chen, C. A., Chen, C.-H., Wang, W.-Y., Chang, S., Hou, Y.-C., Chen, K.-T., Chen, C.-F., et al. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.10.002 · Cited by 143
Liao, C.-H., Pan, S., Guh, J., Chang, Y.-L., Pai, H., Lin, C., & Teng, C. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi041 · Cited by 139
Wang, T., Wang, Y., Kontani, Y., Kobayashi, Y., Sato, Y., Mori, N., & Yamashita, H. (2008) · Endocrinology · doi:10.1210/en.2007-0467 · Cited by 129
The midpoint method for parallelization of particle simulations
Bowers, K. J., Dror, R. O., & Shaw, D. E. (2006) · The Journal of Chemical Physics · doi:10.1063/1.2191489 · Cited by 126
Evodiamine, a constituent of Evodiae Fructus, induces anti‐proliferating effects in tumor cells
Fei, X. F., Wang, B. X., Li, T. J., Tashiro, S., Minami, M., Xing, D. J., & Ikejima, T. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01358.x · Cited by 125
Li, X., Lin, Y., Wang, Q., Yuan, Y., Zhang, H., & Qian, X. H. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.01.050 · Cited by 119
Lee, T.-J., Kim, E. J., Kim, S., Jung, E. M., Park, J., Jeong, S. H., Park, S.-E., Yoo, Y. H., & Kwon, T. K. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0167 · Cited by 111
Anti‐proliferative effects of evodiamine on human prostate cancer cell lines DU145 and PC3
Kan, S., Yu, C., Pu, H., Hsu, J., Chen, M., & Wang, P. S. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21036 · Cited by 99
Zonal methods for the parallel execution of range-limited N-body simulations
Bowers, K. J., Dror, R. O., & Shaw, D. E. (2006) · Journal of Computational Physics · doi:10.1016/j.jcp.2006.06.014 · Cited by 96
Chiou, W.-F., Sung, Y., Liao, J., Shum, A. Y., & Chen, C. (1997) · Journal of Natural Products · doi:10.1021/np960495z · Cited by 91
Perrin, D., van Hille, B., Barret, J.-M. M., Kruczynski, A., Etiévant, C., Imbert, T., & Hill, B. T. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00382-2 · Cited by 89
OGASAWARA, M., Matsubara, T., & Suzuki, H. (2001) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.24.917 · Cited by 86
Wang, C., Li, S., & Wang, M. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.11.019 · Cited by 83
Lü, W., Liu, X., Cao, X., Xue, M., Liu, K., Zhao, Z., Shen, X., Jiang, H., Xu, Y. F., Huang, J. Y., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200139j · Cited by 82
Chen, Z., Hu, G., Li, D., Chen, J., Li, Y., Zhou, H., & Xie, Y. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.02.015 · Cited by 77
Inhibitory effects of evodiamine on the growth of human prostate cancer cell line LNCaP
Kan, S., Huang, W. J., Lin, L., & Wang, P. S. (2004) · International Journal of Cancer · doi:10.1002/ijc.20138 · Cited by 75
Balamurugan, R., Dekker, F. J., & Waldmann, H. (2005) · Molecular BioSystems · doi:10.1039/b503623b · Cited by 70
Evodiamine inhibits adipogenesis via the EGFR–PKCα–ERK signaling pathway
Wang, T., Wang, Y., & Yamashita, H. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.10.046 · Cited by 69
Screening of Natural Compounds for Inhibitory Activity on Colon Cancer Cell Migration.
OGASAWARA, M., Matsubara, T., & Suzuki, H. (2001) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.24.720 · Cited by 68
Liu, Y.-N., Pan, S., Liao, C.-H., Huang, D.-Y., Guh, J., Peng, C.-Y., Chang, Y.-L., & Teng, C. (2009) · Shock · doi:10.1097/shk.0b013e31819940cb · Cited by 66
Wang, B., Mai, Y.-C., Li, Y., Hou, J., Huang, S., Ou, T., Tan, J., An, L., Li, D., & Gu, L. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.12.044 · Cited by 63
Anti‐Proliferative Effects of Evodiamine on Human Thyroid Cancer Cell Line ARO
Chen, M., Yu, C., Wang, S., Pu, H., Kan, S., Lin, L., Chi, C., Ho, L. L., Lee, C., & Wang, P. S. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22716 · Cited by 61
Self-citationEvodiamine induces caspase-dependent apoptosis and S phase arrest in human colon lovo cells
Zhang, C., Fan, X., Xu, X. M., Yang, X., Wang, X., & Liang, H. (2010) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32833d26a9 · Cited by 58
Manly, C. J., Chandrasekhar, J., Ochterski, J. W., Hammer, J. D., & Warfield, B. B. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.10.019 · Cited by 56
Unprecedented Citrinin Trimer Tricitinol B Functions as a Novel Topoisomerase IIα Inhibitor
Du, L., Liu, H., Fu, W., Li, D., Pan, Q., Zhu, T., Geng, M., & Gu, Q. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200511x · Cited by 55
Bak, E. J., Park, H. G., Kim, J. M., Kim, J. M., Yoo, Y.-J., & Cha, J.-H. (2010) · International Journal of Obesity · doi:10.1038/ijo.2009.223 · Cited by 54
New Strategies in the Discovery of Novel Non-Camptothecin Topoisomerase I Inhibitors
Sheng, C., Miao, Z., & Zhang, W. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711797200453 · Cited by 49
Self-citationMinami, H., Fujii, H., Igarashi, T., Itoh, K., TAMANOI, K., Oguma, T., & Sasaki, Y. (2001) · PubMed · Cited by 39
Peixoto, P., Bailly, C., & David‐Cordonnier, M. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-418-0_15 · Cited by 36
Gastroprotective Effect of Fructus Evodiae Water Extract on Ethanol-Induced Gastric Lesions in Rats
Yu, X., Wu, D., Yuan, J., Zhang, R., & Zhi-bi, H. (2006) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x06004491 · Cited by 35
Metadata
- Authors
- Dong, G., Wang, S., Miao, Z., Yao, J., Zhang, Y., Guo, Z., Zhang, W., & Sheng, C.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2012-08-22
- Volume
- 55
- Issue
- 17
- Pages
- 7593-7613
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2320206356
- Cited by
- 186
- References
- 56
- FWCI
- 3.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.